Qu Zhang

Qu Zhang

Company: GlaxoSmithKline

Job title: Director, Clinical Biomarkers, ImmunoOncology


Roles of ctDNA Molecular Response in Drug Development 11:30 am

• ctDNA molecular response (MR) is a well validated approach correlated with long term clinical benefit • Multiple factors associated with performance of MR • Scenarios that MR could help clinical trials and drug developmentRead more

day: Day 2 - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.